IJ Pharmaceutical Research
Scopus by Title (Ref)
1. Design, synthesis, molecular dynamics studies and biological evaluations of 4-hydroxy-5-pyrrolinone-3-carbohydrazides as HIV-1 integrase inhibitors
- Karimi N. , et al.
2. Computational investigation of Y. aloifolia variegate as anti-Human Immunodeficiency Virus (HIV) targeting HIV-1 protease: A multiscale in-silico exploration
- Irsal R.A.P. , et al.
3. Comprehensive Review on Different Analytical Techniques for HIV 1- Integrase Inhibitors: Raltegravir, Dolutegravir, Elvitegravir and Bictegravir
- Jain P. , et al.
4. A Literature Review Focusing on the Antiviral Activity of [1,2,4] and [1,2,3]-triazoles
- Farghaly T.A. , et al.
5. Recent Developments in the Synthesis of HIV-1 Integrase Strand Transfer Inhibitors Incorporating Pyridine Moiety
- Starosotnikov A.M. , et al.
6. Repurposing FDA-approved drugs as HIV-1 integrase inhibitors: an in silico investigation
- Ha C.H.X. , et al.
7. Design, Synthesis, Docking Studies, and Biological Evaluation of Novel 2-Hydroxyacetophenone Derivatives as Anti-HIV-1 Agents
- Oliaie S.S. , et al.
8. A Korean Post-Marketing Surveillance Study of Dolutegravir Single-Agent Tablets in Patients with HIV-1
- Kwon S. , et al.
9. Synthesis, Biological Evaluation, and Molecular Modeling Studies of New 8-methyl-4-oxo-1,4-dihydroquinoline-3-carbohydrazides as Potential Anti-HIV Agents
- Alemi M. , et al.
10. Design, Synthesis, Docking Study, and Biological Evaluation of 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carbohydrazide Derivatives as Anti-HIV-1 and Antibacterial Agents.
- Abdollahi O. , et al.
11. Chalcone-amide, a privileged backbone for the design and development of selective SARS-CoV/SARS-CoV-2 papain-like protease inhibitors
- Valipour M. , et al.
12. Design, Synthesis, and Docking Studies of Thioimidazolyl Diketoacid Derivatives Targeting HIV-1 Integrase
- Karimi N. , et al.
13. Non-nucleoside structured compounds with antiviral activity—past 10 years (2010–2020)
- Denel-Bobrowska M. , et al.
14. The Role of Nanotechnology in Antiviral Regime: An Overview
- Singh R. , et al.
15. Piroxicam Analogs: Design, Synthesis, Docking Study and Biological Evaluation as Promising Anti-HIV-1 Agents
- Imani A. , et al.
16. Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation
- Lotfaliei M. , et al.
17. Design, Synthesis and Docking studies of New Quinazolinone Derivatives as Anti-HIV-1 Agents
- Zebardast T. , et al.
18. Recent advances in small-molecule HIV-1 integrase inhibitors
- Zhang C. , et al.
19. Design, Synthesis, Docking Study and Biological Evaluation of 4-Hydroxy-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide Derivatives as Anti-HIV Agents
- Imani A. , et al.
20. First report for the electrochemical investigation of a new HIV integrase inhibitor dolutegravir: Its voltammetric determination in tablet dosage forms and human urine using a boron-doped diamond electrode
- Allahverdiyeva S. , et al.
21. HIV-1 Reverse Transcriptase/Integrase Dual Inhibitors: A Review of Recent Advances and Structure-activity Relationship Studies
- Mahboubi-Rabbani M. , et al.
22. Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: Current status and future challenges
- Kharkwal H. , et al.
23. Development and genetic drug resistance research of HIV-1 integrase inhibitors
- Liang M.R. , et al.
24. Bioactive Secondary Metabolites from Endophytic Phoma spp.
- Mahish P.K. , et al.